Skip to main content

Advertisement

Log in

Synergism between metallic nanoparticles and antibiotics

  • Mini-Review
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

The discovery of antibiotics in the twentieth century made it possible to treat bacterial infections and revolutionized modern medicine. However, gradually, it is possible to perceive a decrease in the effectiveness of antimicrobial agents against pathogenic isolates, which, together with the low investment in the discovery and/or development of new antibiotics by large pharmaceutical companies since the 1960s, makes it increasingly difficult to treatment of infections caused by these microorganisms. The search for strategies capable of potentiating the effect of existing drugs through the development of new therapeutic approaches, which also have the potential to circumvent bacterial resistance to antibiotics, has become indispensable. In this context, metallic nanoparticles stand out, as they could be used to act synergistically with drugs. Thus, the objective of this review was to present the latest information on the synergistic activity of antibiotics with metallic nanoparticles, pointing out this association as a promising alternative for the preservation of bacterial sensitivity to these drugs. The different metallic nanoparticles can present different benefits in the treatment of bacterial infections, with this being able to potentiate the bacterial activity of antibiotics that are widely used in the clinic, being able to increase the susceptibility in multiresistant microorganisms.

Key points

• Metallic nanoparticles increased the antimicrobial action of drugs;

• Metallic nanoparticles compromise the action of bacterial efflux pumps;

• Biofilm formation was inhibited after treatment with metallic nanoparticles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Source: Created with BioRender.com

Fig. 2

Source: Created with BioRender.com

Similar content being viewed by others

References

Download references

Funding

Maria Anndressa Alves Agreles thanks the Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco (FACEPE) for the Scientific Initiation grant (PIBIC).

This study was partially funded by the National Council for Scientific and Technological Development (CNPq) (426,065/2018–2).

Author information

Authors and Affiliations

Authors

Contributions

MAAA, IDLC, and IMFC: participated in all stages from study design of the review to the final version of the article.

Corresponding author

Correspondence to Isabella Macário Ferro Cavalcanti.

Ethics declarations

Ethics approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agreles, M.A.A., Cavalcanti, I.D.L. & Cavalcanti, I.M.F. Synergism between metallic nanoparticles and antibiotics. Appl Microbiol Biotechnol 106, 3973–3984 (2022). https://doi.org/10.1007/s00253-022-12001-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-022-12001-1

Keywords

Navigation